NOVADEL PHARMA INC. BALANCE SHEETS
AS OF DECEMBER 31, 2009 AND 2008
|
|
|
|
|
|
|
|
|
|
|
|
December
31,
2009 |
|
December
31,
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ASSETS |
|
|
|
|
|
|
|
|
Current Assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
2,663,000 |
|
$ |
4,328,000 |
|
|
Assets held for sale |
|
|
|
|
|
299,000 |
|
|
Deferred financing costs, net of
accumulated amortization of $238,000 and $213,000, respectively |
|
|
|
|
|
25,000 |
|
|
Prepaid expenses and other current assets |
|
|
1,430,000 |
|
|
958,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Current Assets |
|
|
4,093,000 |
|
|
5,610,000 |
|
|
Property and equipment, net |
|
|
324,000 |
|
|
1,447,000 |
|
|
Other assets |
|
|
36,000 |
|
|
259,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL ASSETS |
|
$ |
4,453,000 |
|
$ |
7,316,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS DEFICIENCY |
|
|
|
|
|
|
|
|
Current Liabilities: |
|
|
|
|
|
|
|
|
Secured convertible notes payable, net of
unamortized discount of zero and $403,000, respectively |
|
$ |
|
|
$ |
3,597,000 |
|
|
Accounts payable |
|
|
195,000 |
|
|
654,000 |
|
|
Accrued expenses and other current
liabilities |
|
|
117,000 |
|
|
924,000 |
|
|
Current portion of deferred revenue |
|
|
4,266,000 |
|
|
266,000 |
|
|
Current portion of capital lease
obligations |
|
|
10,000 |
|
|
122,000 |
|
|
|
|
|
|
|
|
|
|
|
Total Current Liabilities |
|
|
4,588,000 |
|
|
5,563,000 |
|
|
|
|
|
|
|
|
|
|
|
Non-current portion of deferred revenue |
|
|
4,202,000 |
|
|
4,468,000 |
|
|
Non-current portion of capital lease
obligations |
|
|
4,000 |
|
|
26,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Liabilities |
|
|
8,794,000 |
|
|
10,057,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COMMITMENTS AND CONTINGENCIES |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
STOCKHOLDERS DEFICIENCY |
|
|
|
|
|
|
|
|
Preferred stock, $.001 par value: |
|
|
|
|
|
|
|
|
Authorized 1,000,000 shares, none issued |
|
|
|
|
|
|
|
|
Common stock, $.001 par value: |
|
|
|
|
|
|
|
|
Authorized 200,000,000 shares, Issued
88,343,457 and 60,692,260 at December 31, 2009 and 2008, respectively |
|
|
89,000 |
|
|
60,000 |
|
|
Additional paid-in capital |
|
|
78,342,000 |
|
|
72,034,000 |
|
|
Accumulated deficit |
|
|
(82,766,000 |
) |
|
(74,829,000 |
) |
|
Less: Treasury stock, at cost, 3,012 shares |
|
|
(6,000 |
) |
|
(6,000 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Stockholders Deficiency |
|
|
(4,341,000 |
) |
|
(2,741,000 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL LIABILITIES AND STOCKHOLDERS
DEFICIENCY |
|
$ |
4,453,000 |
|
$ |
7,316,000 |
|
|
|
|
|
|
|
|
|
|
See accompanying notes to financial
statements.
F-3
|